keyword
https://read.qxmd.com/read/38633030/serious-adverse-drug-events-associated-with-psychotropic-treatment-of-bipolar-or-schizoaffective-disorder-a-17-year-follow-up-on-the-lisie-retrospective-cohort-study
#1
JOURNAL ARTICLE
Petra Truedson, Michael Ott, Lisa Wahlström, Robert Lundqvist, Martin Maripuu, Krister Lindmark, Ingrid Lieber, Ursula Werneke
INTRODUCTION: Mood stabilisers and other psychotropic drugs can lead to serious adverse drug events (ADEs). However, the incidence remains unknown. We aimed to (a) determine the incidence of serious ADEs in patients with bipolar or schizoaffective disorders, (b) explore the role of lithium exposure, and (c) describe the aetiology. METHODS: This study is part of the LiSIE (Lithium-Study into Effects and Side Effects) retrospective cohort study. Between 2001 and 2017, patients in the Swedish region of Norrbotten, with a diagnosis of bipolar or schizoaffective disorder, were screened for serious ADEs to psychotropic drugs, having resulted in critical, post-anaesthesia, or intensive care...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38584476/opioid-induced-respiratory-depression-suspected-of-drug-interaction-in-a-prostate-cancer-patient-a-case-report
#2
JOURNAL ARTICLE
Hiroshi Hamada, Eisuke Suzuki, Mitsufumi Endo, Yukiko Mihara, Sayaka Iketani, Miki Ishida, Akime Miyasato, Kanako Miyazaki
BACKGROUND: Many of the drugs used for the treatment and alleviation of symptoms in cancer patients are known to inhibit or induce cytochrome P450 (CYP). Therefore, it is important to pay attention to the drug interactions of opioid analgesics that are metabolized by CYPs, because for example when using oxycodone metabolized by CYP3A4, it is possible that the effect will be attenuated or enhanced by the concomitant use of drugs that induce or inhibit CYP3A4. Aprepitant, an antiemetic drug used in many patients receiving anticancer drugs, is known as a moderate competitive inhibitor of CYP3A4...
March 2024: Annals of Palliative Medicine
https://read.qxmd.com/read/38413847/a-case-report-of-an-accidental-iatrogenic-dexmedetomidine-overdose-in-an-adult
#3
JOURNAL ARTICLE
Suvi-Maria Tiainen, Jonni Unga, Panu Uusalo
BACKGROUND: Dexmedetomidine is a sedative drug with a wide safety margin. CASE PRESENTATION: We present a case of accidental iatrogenic dexmedetomidine overdose in an adult patient during high-intensity focused ultrasound (HIFU) treatment. This is the first case report of an adult patient receiving an intravenous push of dexmedetomidine. Overdose resulted in severe oversedation, but symptoms receded spontaneously over time. CONCLUSIONS: Dexmedetomidine overdoses are infrequent, and they are usually the result of an administration error...
February 27, 2024: International Journal of Emergency Medicine
https://read.qxmd.com/read/38345228/the-devil-s-in-the-depot-details-case-of-iatrogenic-opioid-intoxication-after-buprenorphine-injection-requiring-surgical-excision
#4
JOURNAL ARTICLE
Simone Vais, Nichole Starr, Maria Castro, Nathan Brand, Alexander Murphy, Ronald Tesoriero, Irina Kryzhanovskaya
Monthly long-acting injectable buprenorphine (LAI-BUP) is a treatment option for moderate to severe opioid use disorder. Safe administration of LAI-BUP requires preexisting opioid tolerance to prevent sedation and respiratory depression. In the event of adverse medication effects including oversedation, LAI-BUP can be surgically excised up to 14 days after administration (https://www.sublocadehcp.com/dosing-administration). However, the manufacturer does not provide guidance on the proper procedure for excision, and no case reports have been published documenting this procedure...
February 12, 2024: Journal of Addiction Medicine
https://read.qxmd.com/read/38313457/propofol-sedation-in-routine-endoscopy-a-case-series-comparing-target-controlled-infusion-vs-manually-controlled-bolus-concept
#5
JOURNAL ARTICLE
Riad Sarraj, Lorenz Theiler, Nima Vakilzadeh, Niklas Krupka, Reiner Wiest
BACKGROUND: Many studies have addressed safety and effectiveness of non-anaesthesiologist propofol sedation (NAPS) for gastrointestinal (GI) endoscopy Target controlled infusion (TCI) is claimed to provide an optimal sedation regimen by avoiding under- or oversedation. AIM: To assess safety and performance of propofol TCI sedation in comparison with nurse-administered bolus-sedation. METHODS: Fouty-five patients undergoing endoscopy under TCI propofol sedation were prospectively included from November 2016 to May 2017 and compared to 87 patients retrospectively included that underwent endoscopy with NAPS...
January 16, 2024: World Journal of Gastrointestinal Endoscopy
https://read.qxmd.com/read/38245963/stimulant-use-and-opioid-related-harm-in-patients-on-long-term-opioids-for-chronic-pain
#6
JOURNAL ARTICLE
Ayesha Appa, Vanessa M McMahan, Kyna Long, Starley B Shade, Phillip O Coffin
BACKGROUND: There is lack of clarity regarding the impact of and optimal clinical response to stimulant use among people prescribed long-term opioid therapy (LTOT) for pain. OBJECTIVE: To determine if a positive urine drug test (UDT) for stimulants was associated with subsequent opioid-related harm or discontinuation of LTOT. DESIGN: Retrospective cohort study. PATIENTS: People living with and without HIV living in a major metropolitan area with public insurance, prescribed LTOT for chronic, non-cancer pain (n=600)...
December 29, 2023: Drug and Alcohol Dependence
https://read.qxmd.com/read/38193734/consciousness-and-general-anesthesia-challenges-for-measuring-the-depth-of-anesthesia
#7
JOURNAL ARTICLE
Yandong Jiang, Jamie Sleigh
The optimal consciousness level required for general anesthesia with surgery is unclear, but in existing practice, anesthetic oblivion, may be incomplete. This article discusses the concept of consciousness, how it is altered by anesthetics, the challenges for assessing consciousness, currently used technologies for assessing anesthesia levels, and future research directions. Wakefulness is marked by a subjective experience of existence (consciousness), perception of input from the body or the environment (connectedness), the ability for volitional responsiveness, and a sense of continuity in time...
February 1, 2024: Anesthesiology
https://read.qxmd.com/read/38174010/postoperative-opioid-induced-respiratory-depression-or-oversedation-requiring-naloxone-treatment-in-a-community-hospital-a-case-series
#8
JOURNAL ARTICLE
Olivia R Newgaard, Toby N Weingarten, Juraj Sprung, Alex T Suginaka, Carmelina Gurrieri
BACKGROUND: Postoperative opioid-induced respiratory depression and oversedation can lead to fatal events and increase perioperative mortality. In reports from major academic centers, naloxone administration has been used as a proxy for severe opioid overdose. Herein, we studied the incidence, clinical characteristics, and outcomes of postoperative naloxone use in a mid-size community hospital. METHODS: This was a retrospective review of adult patients who received naloxone within 48 postoperative hours between July 9, 2017, and May 31, 2022...
2024: Proceedings of the Baylor University Medical Center
https://read.qxmd.com/read/38151248/fixed-dose-phenobarbital-versus-as-needed-benzodiazepines-for-the-management-of-alcohol-withdrawal-in-acute-care-general-internal-medicine
#9
JOURNAL ARTICLE
Samuel Hundert, Jillian McLlarky, Andrew S Dunn, William Markle
OBJECTIVES: The management of patients at risk of severe alcohol withdrawal is challenging because conventional treatment with as-needed benzodiazepines may be ineffective. We created a fixed-dose phenobarbital protocol and compared patient outcomes using this protocol with an as-needed benzodiazepine protocol. METHODS: Patients admitted from the emergency department (ED) to General Medicine from January 1 to June 30, 2022 and treated for alcohol withdrawal with a novel phenobarbital protocol were compared with all of the patients admitted from the ED to General Medicine from January 1 to June 30, 2018, and treated with as-needed benzodiazepines...
January 2024: Southern Medical Journal
https://read.qxmd.com/read/37979844/establishing-the-safety-of-phenobarbital-treatment-of-alcohol-withdrawal-syndrome-on-general-medical-wards-a-retrospective-cohort-study
#10
JOURNAL ARTICLE
Matthew V Ronan, Rahul B Ganatra, Jussi Saukkonen
INTRODUCTION: Concern about adverse effects from phenobarbital limits its use in treating alcohol withdrawal syndrome (AWS) on general medical wards. Benzodiazepines are the recommended treatment for inpatient management of AWS, yet a subset of patients have an inadequate response or experience complications of AWS despite treatment with benzodiazepines. Data supporting an alternative treatment are needed. We set out to estimate the rate of serious adverse events (SAEs) of phenobarbital treatment for AWS on general medical wards...
November 16, 2023: Alcohol
https://read.qxmd.com/read/37976682/caffeine-administration-to-treat-oversedation-after-general-anesthesia-a-retrospective-analysis
#11
JOURNAL ARTICLE
Atousa Deljou, Juraj Sprung, Jalal Soleimani, Darrell R Schroeder, Toby N Weingarten
STUDY OBJECTIVE: Our institution has adopted an informal practice of administering postoperative caffeine to expedite anesthesia recovery for patients with excessive sedation. This study aimed to determine whether caffeine administration was associated with improved sedation recovery and reduced risk of respiratory complications. DESIGN: Single-center, retrospective, observational study. SETTING: Quaternary medical center. PATIENTS: We included adult patients who were admitted to a postanesthesia recovery care unit (PACU) after general anesthesia and had evidence of postoperative sedation (Richmond Agitation Sedation Score [RASS] < 0)...
February 2024: Journal of Clinical Anesthesia
https://read.qxmd.com/read/37774193/retrospective-review-of-intrathecal-hydromorphone-dose-range-and-complications
#12
REVIEW
Jonathan E Charnin, Toby N Weingarten, Darrell R Schroeder, Hans P Sviggum, Erica R Portner, Gregory A Nuttall
BACKGROUND: Optimal intrathecal dosing regimens for hydromorphone are not well established for analgesia after abdominal surgery. OBJECTIVES: We reviewed intrathecal hydromorphone doses and complications because dosing variability has been observed among anesthesiologists. We hypothesized that increasing doses of intrathecal hydromorphone would be associated with improved postoperative analgesia, but with increased rates of opioid-related adverse events. STUDY DESIGN: Retrospective analysis...
September 2023: Pain Physician
https://read.qxmd.com/read/37713329/postanesthesia-care-unit-recovery-time-according-to-volatile-anesthetic-used-in-clinical-practice
#13
JOURNAL ARTICLE
Juraj Sprung, Atousa Deljou, David O Warner, Darrell R Schroeder, Toby N Weingarten
BACKGROUND: Whether volatile anesthetic solubility affects postanesthesia recovery time in clinical practice is unclear. We investigated the association among 3 volatile agents and 2 clinically relevant outcomes-postanesthesia care unit (PACU) recovery time (time from PACU admission to fulfillment of discharge criteria) and oversedation (Richmond Agitation-Sedation Scale score ≤-3)-as a potential contributor to delaying PACU discharge. The volatile agents studied were isoflurane, desflurane, and sevoflurane...
November 1, 2023: Anesthesia and Analgesia
https://read.qxmd.com/read/37599414/comparison-of-phenobarbital-monotherapy-to-a-benzodiazepine-based-regimen-for-management-of-alcohol-withdrawal-syndrome-in-trauma-patients
#14
JOURNAL ARTICLE
L Montana Fleenor, Jennifer R Beavers, William P Tidwell, Leanne Atchison, Edward Woo, Andrew J Medvecz, Robel T Beyene, Kristopher Kast, David Marcovitz, Bradley M Dennis, Oscar D Guillamondegui, Michael C Smith
BACKGROUND: Alcohol withdrawal syndrome (AWS) is associated with increased morbidity and mortality in the trauma population. Benzodiazepines (BZD) are standard of care for AWS; however, given the risk of delirium with BZDs and reports of BZD-refractory withdrawal, phenobarbital (PHB) has emerged as an alternative therapy for AWS. Safety and efficacy studies of PHB for AWS in trauma patients are lacking. Our aim is to compare a BZD versus PHB protocol in the management of AWS in trauma patients...
August 21, 2023: Journal of Trauma and Acute Care Surgery
https://read.qxmd.com/read/37596710/effect-of-lemborexant-on-pharmacokinetics-of-clozapine-a-potential-drug-drug-interaction-mediated-by-time-dependent-inhibition-of-cyp3a4
#15
JOURNAL ARTICLE
Kenya Watanabe, Shingen Misaka, Keiko Kanno-Nozaki, Takaaki Chiyoda, Yuhei Suzuki, Akiko Sato, Takahiro Suto, Junko Kuroda, Kenju Shimomura, Itaru Miura, Hirooki Yabe
Clozapine (CLZ) is extensively used for treatment-resistant schizophrenia (TRS) with caution to avoid serious adverse events such as agranulocytosis and drug-drug interactions (DDIs). In the current report, we present a case of a 35-year-old male non-smoking TRS patient whose steady-state plasma trough concentrations (Ctrough ) of CLZ and its active metabolite, N-desmethylclozapine (NDMC), were significantly increased after initiating oral administration of lemborexant (LEM), a dual orexin receptor antagonist, for the treatment of insomnia...
August 18, 2023: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/37356886/evaluation-of-nonintubated-analgesia-practices-in-critical-care-transport
#16
JOURNAL ARTICLE
Alyson M Esteves, Hannah E Gilchrist, Jacob M Markwood, Molly Bondurant, Matthew A Roginski
OBJECTIVE: Current analgesia recommendations in the prehospital setting are not specific to critical care transport. Variation exists in the recommended agent and dosing strategies. Furthermore, there is a paucity of literature evaluating benzodiazepine and opiate coadministration, which may place patients at risk for respiratory decompensation. METHODS: This was a retrospective chart review of nonintubated adult critical care transport patients between July 1, 2020, and July 1, 2022, who received fentanyl or ketamine during transport...
2023: Air Medical Journal
https://read.qxmd.com/read/37181899/the-therapeutic-use-and-efficacy-of-ketamine-in-alcohol-use-disorder-and-alcohol-withdrawal-syndrome-a-scoping-review
#17
REVIEW
Charlotte E Goldfine, Jeremiah J Tom, Dana D Im, Benjamin Yudkoff, Amit Anand, Joseph J Taylor, Peter R Chai, Joji Suzuki
INTRODUCTION: Alcohol use disorder (AUD) is the most prevalent substance use disorder (SUD) globally. In 2019, AUD affected 14.5 million Americans and contributed to 95,000 deaths, with an annual cost exceeding 250 billion dollars. Current treatment options for AUD have moderate therapeutic effects and high relapse rates. Recent investigations have demonstrated the potential efficacy of intravenous ketamine infusions to increase alcohol abstinence and may be a safe adjunct to the existing alcohol withdrawal syndrome (AWS) management strategies...
2023: Frontiers in Psychiatry
https://read.qxmd.com/read/37173117/enteral-sedation-in-patients-requiring-mechanical-ventilation-during-an-intravenous-analgesic-and-sedative-shortage
#18
JOURNAL ARTICLE
Hassan Khatib, Stephanie B Edwin, Renee Paxton, Christopher Hughes, Carrie Hartner, Samer Al-Samman, Christopher Giuliano
Background: There is a paucity of data evaluating the use of enteral sedation in mechanical ventilation. A sedative shortage resulted in the use of this approach. Purpose: To evaluate the feasibility of using enteral sedatives to decrease intravenous (IV) analgesia and sedative requirements. Materials/Methods: This single-center, retrospective, observational study compared two groups of patients admitted to the ICU who were mechanically ventilated. One group received a combination of enteral and IV sedatives and the second group received IV monotherapy...
May 12, 2023: Journal of Pharmacy Practice
https://read.qxmd.com/read/37145927/implementation-of-required-sedation-assessment-in-nursing-workflow-to-address-naloxone-utilization
#19
JOURNAL ARTICLE
Edward Hardison, Ainsley Bloomer, Meghan K Wally, Erica McArthur, Joseph R Hsu, Susan Bear, Steven Jarrett, Tamar Roomian, D Matthew Sullivan, Karon Wold, Ziqing Yu, Susan Odum, Rachel B Seymour
OBJECTIVE: Opioid-related adverse drug events continue to occur. This study aimed to characterize the patient population receiving naloxone to inform future intervention efforts. DESIGN: We describe a case series of patients who received naloxone in the hospital during a 16-week time frame in 2016. Data were collected on other administered medications, reason for admission to the hospital, pre-existing diagnoses, comorbidities, and demographics. SETTING: Twelve hospitals within a large healthcare system...
2023: Journal of Opioid Management
https://read.qxmd.com/read/37074774/management-of-high-dose-intrathecal-baclofen-pump-explant-a-case-report
#20
Campbell Belisle Haley, Mrinal Agrawal, Keith Newton, Brent Yeung, Rakhi Dayal
BACKGROUND: Intrathecal baclofen (ITB) is a proven, effective treatment for refractory spasticity and chronic pain, with applications ranging from spinal cord injury to amyotrophic lateralsclerosis (ALS). Despite its effectiveness, the withdrawal syndrome of intrathecal baclofen can be life-threatening. CASE REPORT: This case describes the treatment of a patient with chronic spasticity related to ALS with an ITB pump infection requiring explant and a prolonged period of antibiotics before reimplantation...
September 2023: Pain Practice: the Official Journal of World Institute of Pain
keyword
keyword
82002
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.